The latest data, presented at VIVA and The VEINS

The 2022 Late-Breaking Clinical Trial submission portal is closed, and notices of acceptance or rejection have been distributed. To be added to our mailing list and receive future updates, subscribe here.


Overview

Physicians and researchers will present groundbreaking findings from late-breaking clinical trials, follow-up data from major randomized trials and registries, and first-in-man experiences with novel devices or drugs.

The 2022 late-breaking clinical trials will be presented on Monday, October 31 (The VEINS) and Tuesday-Wednesday, November 1-2 (VIVA). Each presentation will be followed by a discussion and Q&A with a panel of expert faculty.

See the complete agendas for VIVA and The VEINS 2022.

Embargo Policy

VIVA embargoes Late-Breaking Clinical Trial information from becoming public until after the commencement of the session as listed in the conference program or on viva-foundation.org. No publication, exhibitor, or affiliated company may disseminate information until after the commencement of the Late-Breaking Clinical Trial session in which it is presented.

Submissions for future conferences

To be added to our mailing list and receive future updates, subscribe here.